<DOC>
	<DOCNO>NCT00261248</DOCNO>
	<brief_summary>The purpose study determine whether vaginal mucosal vaccine give woman history recurrent urinary tract infection reduce number infection occur six-month study period , compare placebo treatment .</brief_summary>
	<brief_title>Vaccine Recurrent Urinary Tract Infections Women</brief_title>
	<detailed_description>Recurrent urinary tract infection ( UTIs ) affect approximately 10 % woman United States . Since antibiotic prophylaxis always effective , alternate treatment need develop . One treatment would immunization vaccine contain bacteria know cause infection . The objective study immunize susceptible woman inactivate bacteria contain vaginal suppository monitor rate reinfection compare group woman treat placebo suppository . Each group patient receive total six suppository first four-months six-month study UTIs side effect record . The infection rate vaccine- placebo-treated woman statistically analyzed determine vaccine efficacy .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Three urinary tract infection previous year Neurogenic bladder Interstitial cystitis Urinary diversion Kidney stone Indwelling catheter</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2003</verification_date>
	<keyword>Phase 2</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Urinary Tract Infection</keyword>
	<keyword>Vaginal Mucosal</keyword>
</DOC>